DCAT Value Chain Insights

FDA and EMA Broaden Review of Impurities in API Manufacturing

The FDA and the European Medicines Agency (EMA) are expanding their scope of investigation to evaluate other active pharmaceutical ingredients (APIs) that contain nitrosamine impurities, an issue...

Digital Strategies in Sourcing and Supply Management

New digital tools hold the potential to transform the pharma customer–supplier relationship, but how? In DCAT Sharp Sourcing LIVE, a livestreamed webinar on Oct. 10, learn how artificial...

A winning pediatric dosage formulation

Information
March 6, 2019
Sponsored by Cambrex

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they...

Read More
Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More
Continuous Flow for APIs and Intermediates (Part 2)

Information
February 13, 2019
Sponsored by Cambrex

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

Read More